https://www.stcc.sg/newsrooms/ Read the latest news, media releases, research highlights, and events from STCC and the global cancer research community en Wed, 21 Oct 2026 14:55:29 +0800 Isomer (https://www.isomer.gov.sg) https://www.stcc.sg/newsrooms/singapore-s-cancer-screening-gap-is-widening-at-a-critical-momenturn:isomer:resource:158029Low participation rates, late diagnoses and younger patients point to the urgent need for a rethink. Some recent health statistics paint a troubling picture.Thu, 05 Feb 2026 00:00:00 +0800News https://www.stcc.sg/newsrooms/national-cancer-centre-s-ravindran-kanesvaran-on-future-of-cancer-care-treatment-costsurn:isomer:resource:158025Measures to strengthen clinical capacity, accelerate innovation in treatment, and ensure more equitable access as Singapore adapts to changing cancer demographics and the growing role of advanced therapies.Mon, 07 Apr 2025 00:00:00 +0800News https://www.stcc.sg/newsrooms/professor-ashok-venkitaraman-elected-as-fellow-of-prestigious-aacr-academyurn:isomer:resource:158028Professor Ashok Venkitaraman, CSI Singapore Director and STCC Board Oversight Committee member, is elected to the 2025 class of Fellows of the prestigious AACR Academy for his pioneering contributions to cancer research.Fri, 14 Mar 2025 00:00:00 +0800News https://www.stcc.sg/newsrooms/partnership-for-advancing-cancer-research-and-biobanking-in-asiaurn:isomer:resource:158027The National Health Research Institutes (NHRI) in Taiwan and the Singapore Translational Cancer Consortium (STCC) sign an MoU to strengthen cross-border biobanking and translational cancer research.Sat, 01 Mar 2025 00:00:00 +0800News https://www.biospectrumasia.com/opinion/30/25467/discovering-a-breakthrough-in-bladder-cancer-treatment-landscape-.htmlurn:isomer:resource:158004In a brief conversation with Biospectrum Asia, Dr Kanesvaran, outlined his extensive expertise in tackling Advanced Bladder Cancer (ABC) and its prophylaxis with reference to recent clinical findings.Wed, 22 Jan 2025 00:00:00 +0800News https://www.stcc.sg/newsrooms/advancing-cancer-research-translation-in-singapore-a-look-back-at-2024urn:isomer:resource:158013Highlights from 2024Fri, 03 Jan 2025 00:00:00 +0800Articles https://www.stcc.sg/newsrooms/stcc-appointment-of-next-co-directorurn:isomer:resource:158031Senior leadership appointment change at STCCThu, 31 Oct 2024 00:00:00 +0800News https://www.stcc.sg/newsrooms/media-coverage-patients-may-get-greater-access-to-novel-cancer-drugs-under-r-d-partnershipurn:isomer:resource:158023STCC named first Southeast Asian member of imCORE — what it means for Singapore.Mon, 29 Jul 2024 00:00:00 +0800News https://www.stcc.sg/newsrooms/stcc-becomes-first-southeast-asian-member-of-roche-s-imcore-networkurn:isomer:resource:158032STCC Becomes First Southeast Asian Member of Roche’s imCORE NetworkWed, 24 Jul 2024 00:00:00 +0800Media Releases https://www.stcc.sg/newsrooms/stcc-and-nccs-collaboration-to-advance-organ-on-chip-platformurn:isomer:resource:158030Singapore Translational Cancer Consortium (STCC) and the National Cancer Centre Singapore (NCCS) announce a research collaboration to develop a Philips-enabled Organ-on-Chip platform to scale tumour organoid models and accelerate pre-clinical cancer research in Singapore.Sat, 30 Dec 2023 00:00:00 +0800News https://www.stcc.sg/newsrooms/stcc-meets-with-cancermodels-orgurn:isomer:resource:158033STCC meets with CancerModels.org to learn more about their open-source patient-derived cancer model resource and explore potential collaboration opportunities.Thu, 30 Nov 2023 00:00:00 +0800News https://www.cris.sg/news-and-events/news/230924-cancer-research-michal-hoppe/urn:isomer:resource:158006Mon, 06 Nov 2023 00:00:00 +0800Articles https://channelnewsasia.com/singapore/healthcare-providers-foster-culture-trust-amid-digital-revolution-artificial-intelligence-telemedicine-3886006urn:isomer:resource:158011The healthcare scene is making huge strides in recent years, driven by a rise in digital health technologies such as telemedicine and artificial intelligence. Wed, 01 Nov 2023 00:00:00 +0800News https://www.linkedin.com/feed/update/urn:li:activity:7114791176070725632/urn:isomer:resource:158009Sat, 30 Sep 2023 00:00:00 +0800News https://news.nus.edu.sg/treatment-diagnosis-of-blood-cancer/urn:isomer:resource:158008NUS scientists seek to exploit vulnerabilities in cancer development pathways to revolutionise treatment strategies for high-risk myeloma.Tue, 12 Sep 2023 00:00:00 +0800News https://aacrjournals.org/cancerdiscovery/article/13/5/1144/726201/Patterns-of-Oncogene-Coexpression-at-Single-Cellurn:isomer:resource:158015Thu, 04 May 2023 00:00:00 +0800Publications https://www.linkedin.com/feed/update/urn:li:activity:7059754757837455360/urn:isomer:resource:158020The Singapore Translational Cancer Consortium (STCC), has signed its first cross-border partnership with the Australian Victorian Cancer Biobank (VCB) to foster collaborations in translational oncology research.Thu, 04 May 2023 00:00:00 +0800News https://www.straitstimes.com/singapore/health/moh-supporting-development-of-mrna-cancer-vaccines-in-singaporeurn:isomer:resource:158021Tue, 14 Feb 2023 00:00:00 +0800News https://www.stcc.sg/newsrooms/mirxes-strengthens-global-fight-against-cancerurn:isomer:resource:158024MiRXES today signed an MOU with major Singapore public healthcare institutions and universities to lead a large-scale collaborative effort combining miRNA and DNA methylation research for early cancer detection.Thu, 07 Jul 2022 00:00:00 +0800Media Releases https://www.fiercebiotech.com/medtech/delfi-diagnostics-ai-based-blood-test-detects-80-early-stage-lung-cancer-cases-study-findsurn:isomer:resource:158022Delfi Diagnostics’ liquid biopsy test uses machine learning to spot changes in patients’ DNA fragmentation profiles that indicate the presence of cancerous cells. According to a new study, this method can spot about 90% of lung cancers. (Getty Images)Mon, 23 Aug 2021 00:00:00 +0800Articles https://www.facebook.com/CNA938/videos/440014317426757/urn:isomer:resource:158003A new public–private partnership will accelerate personalised healthcare adoption in Singapore, including precision oncology. Associate Professor David Tan (NUH/NCIS) discusses setting up personalised care and the potential impact of a clinico-genomic database on future cancer treatment on Health Matters with Daniel Martin on CNA938.Thu, 25 Feb 2021 00:00:00 +0800News https://www.stcc.sg/newsrooms/news-and-updatesnew-personalised-healthcare-partnership-to-improveurn:isomer:resource:158026STCC, NCCS, NCIS and Roche sign an MoU to build Singapore’s clinico-genomic database and advance national precision oncology infrastructure. Tue, 09 Feb 2021 00:00:00 +0800Media Releases https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241783urn:isomer:resource:158005The aim of this study was to ascertain general views regarding the overall perceived value of ethics review processes; to measure perceptions about local IRB functions and characteristics; to identify IRB functions and characteristics viewed as important; and to compare these views with those of other international studies.Mon, 08 Feb 2021 00:00:00 +0800Publications https://pubmed.ncbi.nlm.nih.gov/33217343/urn:isomer:resource:158007Mon, 23 Nov 2020 00:00:00 +0800Publications https://pubmed.ncbi.nlm.nih.gov/32301274/urn:isomer:resource:158019This expert opinion review examines the key challenges to the clinical adoption of NGS-based diagnostics in Singapore, provides recommendations on impactful initiatives to improve adoption, and also offers practical guidance on specific cancer types in which NGS-based diagnostics are appropriate for use in Singapore. Thu, 22 Oct 2020 00:00:00 +0800Publications